Toxidermies

Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 cases
Kridin K, Brüggen MC, Walsh S, Bensaid B, Ranki A, Oppel E, Meyersburg D, Chua SL, Seeli C, Sandberg H, French LE, Vorobyev A, Ingen-Housz-Oro S.
J Eur Acad Dermatol Venereol. 2023 Apr;37(4):753-762.
doi: 10.1111/jdv.18808. Epub 2022 Dec 19. PMID: 36479739.

Novel inflammatory markers and in-hospital mortality in epidermal necrolysis-A monocentric study of 137 patients
Bettuzzi T, Lalevée S, Badaoui B, Hua C, Wolkenstein P, de Prost N, Ingen-Housz-Oro S.
J Eur Acad Dermatol Venereol. 2023 Mar;37(3):e382-e383. doi: 10.1111/jdv.18578. Epub 2022 Oct 3.
PMID: 36149304 No abstract available.

Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management
Thorel D, Ingen-Housz-Oro S, Benaïm D, Daien V, Gabison E, Saunier V, Béral L, Touboul D, Brémond-Gignac D, Robert M, Vasseur R, Royer G, Dereure O, Milpied B, Bernier C, Welfringer-Morin A, Bodemer C, Cordel N, Tauber M, Burillon C,
Servant M, Couret C, Vabres B, Tétart F, Cassagne M, Kuoch MA, Muraine M, Delcampe A, Gueudry J.
Orphanet J Rare Dis. 2023 Mar 11;18(1):51.
doi: 10.1186/s13023-023-02616-6. PMID: 36906580 Free PMC article. Review.

Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System
Jourdain H, Hoisnard L, Sbidian E, Zureik M.
BioDrugs. 2023 Mar 6.
doi: 10.1007/s40259-023-00584-8. Online ahead of print. PMID: 36877448.

Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus
Ingen-Housz-Oro S, Schmidt V, Ameri MM, Abe R, Brassard A, Mostaghimi A, Paller AS, Romano A, Didona B,
Kaffenberger BH, Ben Said B, Thong BYH, Ramsay B, Brezinova E, Milpied B, Mortz CG, Chu CY, Sotozono C, Gueudry J,
Fortune DG, Dridi SM, Tartar D, Do-Pham G, Gabison E, Phillips EJ, Lewis F, Salavastru C, Horvath B, Dart J, Setterfield J, Newman J, Schulz JT, Delcampe A, Brockow K, Seminario-Vidal L, Jörg L, Watson MP, Gonçalo M, Lucas M, Torres M,
Noe MH, Hama N, Shear NH, O'Reilly P, Wolkenstein P, Romanelli P, Dodiuk-Gad RP, Micheletti RG, Tiplica GS, Sheridan R, Rauz S, Ahmad S, Chua SL, Flynn TH, Pichler W, Le ST, Maverakis E, Walsh S, French LE, Brüggen MC.
Orphanet J Rare Dis. 2023 Feb 22;18(1):33.
doi: 10.1186/s13023-023-02631-7.

Severe allergic contact connubial dermatitis to Nigella sativa oil due to repeated contacts to beard cosmetics
Assier H, Kouby F, Ingen-Housz-Oro S, Roux C.
Contact Dermatitis. 2022 Dec 9.
doi: 10.1111/cod.14266. Online ahead of print. PMID: 36494318 No abstract available.

Cimetidine and racecadotril: Unusual culprit drugs of a severe cutaneous adverse reaction
Kechichian E, Weill A, Ingen-Housz-Oro S, Assier H.
Contact Dermatitis. 2022 Nov;87(5):451-452.
doi: 10.1111/cod.14176. Epub 2022 Jul 1. PMID: 35715974 No abstract available.

Pustular allergic contact dermatitis of the dorsum of hands related to rubber gloves additives
Merhy R, Weill A, Ingen-Housz-Oro S, Assier H.
Contact Dermatitis. 2022 Aug;87(2):199-201.
doi: 10.1111/cod.14124. Epub 2022 Apr 17. PMID: 35398922 No abstract available.

Psychotherapeutic interventions for burns patients and the potential use with Stevens-Johnson syndrome and toxic epidermal necrolysis patients: A systematic integrative review
O'Reilly P, Meskell P, Whelan B, Kennedy C, Ramsay B, Coffey A, Fortune DG, Walsh S, Ingen-Housz-Oro S, Bunker CB, Wilson DM, Delaunois I, Dore L, Howard S, Ryan S.
PLoS One. 2022 Jun 27;17(6):e0270424.
oi: 10.1371/journal.pone.0270424. eCollection 2022. PMID: 35759493 Free PMC article.

Epidermal necrolysis: characterization of different phenotypes using an unsupervised clustering analysis
Bettuzzi T, Hua C, Diaz E, Colin A, Wolkenstein P, de Prost N, Ingen-Housz-Oro S.
Br J Dermatol. 2022 Jun;186(6):1037-1039.
doi: 10.1111/bjd.21009. Epub 2022 Apr 6. PMID: 35007333 No abstract available.

Biases associated with epidermal necrolysis reporting in pharmacovigilance: An exploratory analysis using World Health Organization VigiBase
Bettuzzi T, Ingen-Housz-Oro S, Maison P, de Prost N, Wolkenstein P, Lebrun-Vignes B, Sbidian E.
Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):434-441. doi: 10.1002/pds.5399. Epub 2021 Dec 28.
PMID: 34907614.

Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database
Bettuzzi T, Drucker A, Staumont-Sallé D, Bihan K, Lebrun-Vignes B, Sbidian E.
J Am Acad Dermatol. 2022 Feb;86(2):431-433. doi: 10.1016/j.jaad.2021.09.050. Epub 2021 Sep 30.
No abstract available.

Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study
Kridin K, Brüggen MC, Chua SL, Bygum A, Walsh S, Nägeli MC, Kucinskiene V, French L, Tétart F, Didona B, Milpied B,
Ranki A, Salavastru C, Brezinová E, Divani-Patel S, Lorentzen T, Nagel JL, Valiukeviciene S, Karpaviciute V, Tiplica GS, Oppel E, Oschmann A, de Prost N, Vorobyev A, Ingen-Housz-Oro S.
JAMA Dermatol. 2021 Aug 25:e213154.
doi: 10.1001/jamadermatol.2021.3154. Online ahead of print.PMID: 34431984.

Clinical and histological features of fixed drug eruption: a single-centre series of 73 cases with comparison between bullous and non-bullous forms
Perron E, Viarnaud A, Marciano L, Karkouche R, Wechsler J, De Prost N, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Ortonne N.
Eur J Dermatol. 2021 Jun 1;31(3):372-380.
doi: 10.1684/ejd.2021.4051.PMID: 34309522.

Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus
Brüggen MC, Le ST, Walsh S, Toussi A, de Prost N, Ranki A, Didona B, Colin A, Horváth B, Brezinova E, Milpied B, Moss C, Bodemer C, Meyersburg D, Salavastru C, Tiplica GS, Howard E, Bequignon E, Bouwes Bavinck JN, Newman J, Gueudry J, Nägeli M, Zaghbib K, Pallesen K, Bygum A, Joly P, Wolkenstein P, Chua SL, Le Floch R, Shear NH, Chu CY, Hama N, Abe R, Chung WH, Shiohara T, Arden-Jones M, Romanelli P, Phillips EJ, Stern RS, Cotliar J, Micheletti RG, Brassard A, Schulz JT, Dodiuk-Gad RP, Dominguez AR, Paller AS, Vidal LS, Mostaghimi A, Noe MH, Worswick S, Tartar D, Sheridan R,
Kaffenberger BH, Shinkai K, Maverakis E, French LE, Ingen-Housz-Oro S.
Br J Dermatol. 2021 Mar 3.
doi: 10.1111/bjd.19893. Online ahead of print. PMID: 33657677.

Involvement of small-diameter nerve fibres in long-term chronic pain after Stevens-Johnson syndrome or toxic epidermal necrolysis. A neurophysiological assessment
Lefaucheur JP, Hajj C, Valeyrie-Allanore L, Colin A, Ng Wing Tin S, de Prost N, Wolkenstein P,
Chosidow O, Ingen-Housz-Oro S.
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e218-e221.
doi: 10.1111/jdv.16940. Epub 2020 Oct 15. PMID: 32920914 No abstract available.

Carrying out local care for epidermal necrolysis: survey of practices
Ingen-Housz-Oro S, Le Floch R, Alves A, Colin A, Ouedraogo R, Welfringer A, Dereure O, Besnard N, Bodemer C, Bernier C, Hoffmann C, Tétart F, Carpentier D, Cordel N, Elie E, Tauber M, Soubiron L, Milpied B, de Prost N.
J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e155-e157.
doi: 10.1111/jdv.16884. Epub 2020 Oct 7. PMID: 32810302 No abstract available.

Characterization of drug-induced cutaneous lupus: Analysis of 1994 cases using the WHO pharmacovigilance database
Kawka L, Mertz P, Chasset F, Lebrun-Vignes B, Salem JE, Arnaud L.
AutoimmunRev. 2021 Jan;20(1):102705.
doi: 10.1016/j.autrev.2020.102705. Epub 2020 Nov 11. PMID: 33188917 No abstract available.

Acute lung injury in mechanically ventilated patients with epidermal necrolysis: an exposed-unexposed retrospective cohort study
Lalevée S, Catano J, Ingen-Housz-Oro S, Surenaud M, Tran Van Nhieu J, Schlemmer F, Bendib I, Mekontso-Dessap A,
Hue S, de Prost N.
Burns Trauma. 2020 Dec 8;8:tkaa041.
doi: 10.1093/burnst/tkaa041. eCollection 2020. PMID: 33324706 Free PMC article. No abstract available.

Changing spectrum of suspected drugs of Epidermal Necrolysis: an WHO pharmacovigilance database analysis from 1997 to 2020
Bettuzzi T, Ingen-Housz Oro S, Chinchilla Purtillo C, Le Cleach L, Maison P, de Prost N, Wolkenstein P,
Lebrun-Vignes B, Sbidian E.
J Am Acad Dermatol. 2020 Nov 17:S0190-9622(20)33007-3.
doi: 10.1016/j.jaad.2020.10.091. Online ahead of print. PMID: 33217509 No abstract available.

Management of ocular involvement in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: french national audit of practices, literature review, and consensus agreement
Thorel D, Ingen-Housz-Oro S, Royer G, Delcampe A, Bellon N, Bodemer C, Welfringer-Morin A, Bremond-Gignac D,
Robert MP, Tauber M, Malecaze F, Dereure O, Daien V, Colin A, Bernier C, Couret C, Vabres B, Tetart F, Milpied B, Cornut T,
Ben Said B, Burillon C, Cordel N, Beral L, de Prost N, Wolkenstein P, Muraine M, Gueudry J.
Orphanet J Rare Dis. 2020 Sep 22;15(1):259.
doi: 10.1186/s13023-020-01538-x. PMID: 32962748 Free PMC article. Review.

The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study
Benhabib A, Ioughlissen S, Ratignier-Carbonneil C, Maison P.
BMJ Open. 2020 Mar 4;10(3):e034033.
doi: 10.1136/bmjopen-2019-034033. PMID: 32139487 Free PMC article.

Characterization of auto-immune hepatitis associated with the use of anti-TNFα agents: An analysis of 389 cases in VigiBase
Vollmer O, Felten R, Mertz P, Lebrun-Vignes B, Salem JE, Arnaud L.
AutoimmunRev. 2020 Mar;19(3):102460.
doi: 10.1016/j.autrev.2020.102460. Epub 2020 Jan 7. PMID: 31917266 Review.

Chronic pain: a long-term sequela of epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis) - prevalence, clinical characteristics and risk factors
Lefaucheur JP, Valeyrie-Allanore L, Ng Wing Tin S, Abgrall G, Colin A, Hajj C, de Prost N, Wolkenstein P, Ingen-Housz-Oro S, Chosidow O.
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):188-194.
doi: 10.1111/jdv.16891. Epub 2020 Sep 22. PMID: 32810314.

Idiopathic Stevens-Johnson syndrome and toxic epidermal necrolysis: Prevalence and patients' characteristics
Chaby G, Ingen-Housz-Oro S, De Prost N, Wolkenstein P, Chosidow O, Fardet L.
J Am Acad Dermatol. 2019 May;80(5):1453-1455.
doi: 10.1016/j.jaad.2018.10.058. Epub 2018 Nov 2. PMID: 30395917 No abstract available.

Incidence of and mortality from epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis) in France during 2003-16: a four-source capture-recapture estimate
Chaby G, Maldini C, Haddad C, Lebrun-Vignes B, Hemery F, Ingen-Housz-Oro S, Gonzalez-Chiappe S, Wolkenstein P, Chosidow O, Mahr A, Fardet L.
Br J Dermatol. 2020 Mar;182(3):618-624.
doi: 10.1111/bjd.18424. Epub 2019 Oct 22. PMID: 31396952.

Health-related quality of life and long-term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients
Ingen-Housz-Oro S, Alves A, Colin A, Ouedraogo R, Layese R, Canoui-Poitrine F, Chosidow O, Mekontso-Dessap A, Wolkenstein P, de Prost N.
Br J Dermatol. 2020 Apr;182(4):916-926.
doi: 10.1111/bjd.18387. Epub 2019 Oct 15. PMID: 31385287.

Lookalike and soundalike drugs: a potential cause of cutaneous adverse reactions to drugs
Cassius C, Davis CJ, Bravard P, Carre-Gislard D, Modiano P, Lebrun-Vignes B, Ingen-Housz-Oro S, Chosidow O.
Br J Dermatol. 2019 Sep;181(3):626-627.
doi: 10.1111/bjd.17842. Epub 2019 Jun 18.

Incidence of bloodstream infections and predictive value of qualitative and quantitative skin cultures of patients with overlap syndrome or toxic epidermal necrolysis: A retrospective observational cohort study of 98 cases
Aude Lecadet, Paul-Louis Woerther, Camille Hua, Audrey Colin, Camille Gomart, Jean-Winoc Decousser,
Armand Mekontso Dessap, Pierre Wolkenstein , Olivier Chosidow, Nicolas de Prost, Saskia Ingen-Housz-Oro.
doi: 10.1016/j.jaad.2019.03.030. PMID: 30890340.

Cytopenia induced by low-dose methotrexate: An analysis of 433 cases from the French pharmacovigilance database
Lalevée S, Lebrun-Vignes B, Simon C, Laugier D, Fardet L.
French Network of Regional Centres of Pharmacovigilance. Eur J Intern Med. 2019 Sep;67:97-101.
doi: 10.1016/j.ejim.2019.07.016. Epub 2019 Jul 23. PMID: 31350129.

Dark skin phototype is associated with more severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis
Thorel D, Delcampe A, Ingen-Housz-Oro S, Hajj C, Gabison E, Chosidow O, Wolkenstein P, Royer G, Ezzedine K, Muraine M, Gueudry J.
Br J Dermatol. 2019 Jul;181(1):212-213.
doi: 10.1111/bjd.17627. Epub 2019 Apr 29. PMID: 30633324 No abstract available.

Individual- and hospital-level factors associated with epidermal necrolysis mortality: a nationwide multilevel study, France, 2012-2016
Traikia C, Hua C, Le Cleach L, de Prost N, Hemery F, Bettuzzi T, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S, Sbidian E.
Br J Dermatol. 2020 Apr;182(4):900-906.
doi: 10.1111/bjd.18294. Epub 2019 Sep 4. PMID: 31260078.

Interventions for erythema multiforme: a systematic review
de Risi-Pugliese T, Sbidian E, Ingen-Housz-Oro S, Le Cleach L.
J Eur Acad Dermatol Venereol. 2019 May;33(5):842-849.
doi: 10.1111/jdv.15447. Epub 2019 Feb 28. PMID: 30680804.

Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients
Hefez L, Zaghbib K, Sbidian E, Valeyrie-Allanore L, Allain M, Duong TA, Colin A, Bellivier F, Romano H, de Prost N,
Chazelas K, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S.
Br J Dermatol. 2019 May;180(5):1206-1213.
doi: 10.1111/bjd.17267. Epub 2018 Dec 3. PMID: 30282109.

Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: Proportion and determinants of underreporting to pharmacovigilance
Chaby G, Lebrun-Vignes B, Haddad C, Hemery F, Ingen-Housz-Oro S, de Prost N, Wolkenstein P, Chosidow O, Fardet L.
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1344-1346.
doi: 10.1016/j.jaip.2018.09.028. Epub 2018 Oct 5. PMID: 30292922 No abstract available.

Antibiotic Prescribing Rate in Lebanese Community Pharmacies: A Nationwide Patient-Simulated Study of Acute Bacterial Rhinosinusitis
Yaacoub SG, Lahoud NA, Francis NJ, Rahme DW, Murr TH, Maison PF, Saleh NG.
J Epidemiol Glob Health. 2019 Mar;9(1):44-49.
doi: 10.2991/jegh.k.190305.001. PMID: 30932389 Free PMC article.

Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases
Garel B, Ingen-Housz-Oro S, Afriat D, Prost-Squarcioni C, Tétart F, Bensaid B, Bara Passot C, Beylot-Barry M, Descamps V, Duvert-Lehembre S, Grootenboer-Mignot S, Jeudy G, Soria A, Valnet-Rabier MB, Barbaud A, Caux F, Lebrun-Vignes B.
Br J Clin Pharmacol. 2019 Mar;85(3):570-579.
doi: 10.1111/bcp.13827. Epub 2019 Jan 4. PMID: 30511379 Free PMC article.

A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices
Kechichian E, Ingen-Housz-Oro S, Sbidian E, Hemery F, Bernier C, Fite C, Delaunay J, Staumont-Sallé D, Toukal F, Dupin N, Abasq C, Samimi M, Picard C, Hebert V, Prost C, Monfort JB, Milpied B, Wolkenstein P, Chosidow O.
Br J Dermatol. 2018 Oct;179(4):1009-1011.
doi: 10.1111/bjd.16928. Epub 2018 Aug 16. PMID: 29957881 No abstract available.

Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin and pristinamycin: clinical history and patch testing
El Khoury M, Assier H, Gener G, Paul M, Haddad C, Chosidow O, Wolkenstein P, Ingen-Housz-Oro S.
Br J Dermatol. 2018 Oct;179(4):978-979.
doi: 10.1111/bjd.16738. Epub 2018 Jul 20. PMID: 29747236 No abstract available.

Severe cutaneous adverse reactions due to inappropriate medication use
Chaby G, Valeyrie-Allanore L, Duong TA, Lebrun-Vignes B, Milpied B, Sassolas B, Tetart F, Wolkenstein P,
Chosidow O, Fardet L.
Br J Dermatol. 2018 Aug;179(2):329-336.
doi: 10.1111/bjd.16365. Epub 2018 May 14. PMID: 29352771.

Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched Analyses
Poizeau F, Gaudin O, Le Cleach L, Duong TA, Hua C, Hotz C, Ingen-Housz-Oro S, Sbidian E, Zehou O, Colin A, de Prost N, Lebrun-Vignes B, Chosidow O, Wolkenstein P, Fardet L.
J Invest Dermatol. 2018 Jun;138(6):1293-1300.
doi: 10.1016/j.jid.2017.12.034. Epub 2018 Jan 31. PMID: 29369774.

Epidermalnecrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)
Ingen-Housz-Oro S, Duong TA, Bensaid B, Bellon N, de Prost N, Lu D, Lebrun-Vignes B, Gueudry J, Bequignon E, Zaghbib K, Royer G, Colin A, Do-Pham G, Bodemer C, Ortonne N, Barbaud A, Fardet L, Chosidow O, Wolkenstein P.
French National Reference Center for ToxicBullous Dermatoses. Orphanet J Rare Dis. 2018 Apr 10;13(1):56.
doi: 10.1186/s13023-018-0793-7. PMID: 29636107 Free PMC article.